MIGALDENDRANIB
UNII VYR55UWU8M

Substance Identification & Data

This profile provides standardized clinical and technical data for Migaldendranib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VYR55UWU8M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2757474-53-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VYR55UWU8M

CAS Registry Number

2757474-53-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MIGALDENDRANIB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203088

National Cancer Institute reference terminology for clinical and research data.

INN ID

12598

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-158

Identifier assigned by the United States Adopted Names Council.

Substance Type

polymer

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Migaldendranib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MIGALDENDRANIB

Common Names & Synonyms

2-((1-(1-(5-((.XI.)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-1H-PYRROL-3-YL)-1,6-DIOXO-9,12,15-TRIOXA-2,5-DIAZAHEPTADECAN-17-YL)-1H-1,2,3-TRIAZOL-4-YL)METHOXY)ETHYL ETHER WITH ABOUT 11% OF HYDROXY GROUPS OF THE REGULAR DENDRIMER .ALPHA.,.ALPHA.',.ALPHA.'',.ALPHA.'''-(ETHYLENEDINITRILO)TETRAKIS(.OMEGA.-HEXADECAKIS(3-((2-HYDROXYETHYL)AMINO)-3-OXOPROPYL)-DENDRO G4-((3-OXOPROPANE-1,3-DIYL)AZANEDIYLETHYLENENITRILO))

2-PROPENOIC ACID, METHYL ESTER, POLYMER WITH 1,2-ETHANEDIAMINE, REACTION PRODUCTS WITH N-(2-AMINOETHYL)-5-((5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE, 3-(2-(2-(2-AZIDOETHOXY)ETHOXY)ETHOXY)PROPANOIC ACID, ETHANOLAMINE AND 2-(2-(2-PROPYN-1-YLOXY)ETHOXY)ETHANAMINE

MIGALDENDRANIB [INN]

MIGALDENDRANIB [USAN]